383 related articles for article (PubMed ID: 11223987)
1. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Koga S; Kondo Y; Komata T; Kondo S
Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
[TBL] [Abstract][Full Text] [Related]
3. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
4. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
5. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Iwado E; Daido S; Kondo Y; Kondo S
Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Kondo Y; Komata T; Kondo S
Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
12. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
[TBL] [Abstract][Full Text] [Related]
13. Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells.
Nashimoto T; Komata T; Kanzawa T; Aoki H; Endo S; Kon T; Uzuka T; Takahashi H; Kondo S; Tanaka R
Int J Hyperthermia; 2005 Nov; 21(7):615-29. PubMed ID: 16278167
[TBL] [Abstract][Full Text] [Related]
14. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts.
You Y; Geng X; Zhao P; Fu Z; Wang C; Chao S; Liu N; Lu A; Gardner K; Pu P; Kong C; Ge Y; Judge SI; Li QQ
Cell Mol Life Sci; 2007 Mar; 64(5):621-31. PubMed ID: 17310280
[TBL] [Abstract][Full Text] [Related]
17. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
[TBL] [Abstract][Full Text] [Related]
18. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
[TBL] [Abstract][Full Text] [Related]
20. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
